ReviewCardiovascular diabetology2019

The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus.

Salvatore Carbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.